Second Sight Medical Products Inc (VANIW)

$0.01

up-down-arrow $-0.10 (-90.82%)

As on 12-Mar-2024 14:36EDT

Market cap

info icon

--

Revenue (TTM)

info icon

--

P/E Ratio

info icon

--

P/B Ratio

info icon

--

Div. Yield

info icon

--

Second Sight Medical Products Inc (VANIW) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading

Max:loading Min:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 0.01 High: 0.05

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    --

  • ROEROE information

    --

  • ROCEROCE information

    --

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    --

  • Debt to EquityDebt to Equity information

    --

  • Book ValueBook Value information

    --

  • EPSEPS information

    --

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    --

10 Years Aggregate

CFO

$-205.15 Mln

EBITDA

$-250.04 Mln

Net Profit

$-239.20 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Second Sight Medical Products Inc (VANIW)
-- -- -90.8 -87.3 -- -- --
BSE Sensex*
-8.6 2.9 1.8 -5.1 6.9 8.1 11.3
As on 12-Mar-2024  |  *As on 18-Jun-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Second Sight Medical Products Inc (VANIW)

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and...  implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. 

  • Co-Founder, CEO & Director

    Mr. Adam Mendelsohn Ph.D.

  • Co-Founder, CEO & Director

    Mr. Adam Mendelsohn Ph.D.

  • Headquarters

    EmeryVille, CA

  • Website

    https://www.vivani.com

Edit peer-selector-edit

FAQs for Second Sight Medical Products Inc (VANIW)

The share price of Second Sight Medical Products Inc (VANIW) is $0.01 (NASDAQ) as of 12-Mar-2024 14:36 EDT. Second Sight Medical Products Inc (VANIW) has given a return of -87.26% in the last 1 years.




PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2023
-0.22
0.27
2022
-0.12
0.02
2021
--
--
2020
--
--
2019
--
--

The 52-week high and low of Second Sight Medical Products Inc (VANIW) are Rs -- and Rs -- as of 18-Jun-2026.

Second Sight Medical Products Inc (VANIW) has a market capitalisation of -- as on 12-Mar-2024. As per SEBI classification, it is a company.

Before investing in Second Sight Medical Products Inc (VANIW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.